CLINICAL_TRIALS
trial_result
· 2009-03-12
Clinical Trial Update: Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267) [Phase 3]
Summary
A Phase 3 trial comparing temozolomide to dacarbazine in stage IV metastatic melanoma has completed, with results posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Melanoma | Phase 3 | Status: COMPLETED | Results posted: 2009-03-12